The correlation of clusterin binding affinity to chemotherapeutic agents with chemoresistance in ovarian cancer cells / 대한산부인과학회지
Korean Journal of Obstetrics and Gynecology
;
: 738-743, 2008.
Article
in Korean
| WPRIM
| ID: wpr-54310
ABSTRACT
OBJECTIVE:
The purpose of this study was to determine the mechanism of action of clusterin?known as a chemo-resistance protein?by analyzing its binding with chemotherapeutic agents and elucidating its relation with drug resistance.METHODS:
Chemotherapeutic agents were diluted with coating buffer and coated onto 96 well plates. We then had these agents cross-react with purified clusterin and wash the wells to remove residual clusterin. We quantified the amount of clusterin with optical density (OD) measured by binding peroxidase-conjugated secondary antibody associated with mouse monoclonal clusterin antibody. To determine if anticancer drug-clusterin binding is related to chemotherapeutic agent resistance, we compared survival rates in the SKOV-3 cell line, which rarely secretes clusterin. We compared a group of SKOV-3 cells treated with a chemotherapeutic agent and a group treated with both the agent and clusterin, by means of XTT.RESULTS:
In binding tests using ELISA OD, ratios of paclitaxel, cisplatin, carboplatin, topotecan, Adriamycin, etoposide, and 5-fluoruracil (5-FU) were 2.34, 2.40, 0.52, 2.44, 1.602, 1.14, and 1.13, respectively. Topotecan, cisplatin, and paclitaxel showed relatively higher binding. In addition, when these drugs were treated with clusterin in SKOV-3 cells, anticancer resistance increased (P<0.05).CONCLUSIONS:
The anticancer drug resistance endowed by clusterin is considered to be related to its binding with chemotherapeutic agents.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Ovarian Neoplasms
/
Drug Resistance
/
Enzyme-Linked Immunosorbent Assay
/
Doxorubicin
/
Cell Line
/
Survival Rate
/
Carboplatin
/
Cisplatin
/
Paclitaxel
/
Topotecan
Limits:
Animals
Language:
Korean
Journal:
Korean Journal of Obstetrics and Gynecology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS